However, it significantly potentiated EGFR TKI-induced inhibition of viability in all three NSCLC cell lines (Fig. 2a, b), which was accompanied by increased activation of apoptosis (Fig. 2c–f; Supplementary Fig. 2C, D). This evidence concerns the gene EGFR and non-small cell lung carcinoma.